ERIS Lifesciences consolidated net profit rises 200.10% in the March 2026 quarter

Sales rise 7.07% to Rs 752.29 crore

Net profit of ERIS Lifesciences rose 200.10% to Rs 281.61 crore in the quarter ended March 2026 as against Rs 93.84 crore during the previous quarter ended March 2025. Sales rose 7.07% to Rs 752.29 crore in the quarter ended March 2026 as against Rs 702.60 crore during the previous quarter ended March 2025.

For the full year,net profit rose 76.08% to Rs 619.52 crore in the year ended March 2026 as against Rs 351.84 crore during the previous year ended March 2025. Sales rose 8.18% to Rs 3114.89 crore in the year ended March 2026 as against Rs 2879.26 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	752.29	702.60	7	3114.89	2879.26	8
OPM %	36.21	35.92	-	35.96	35.33	-
PBDT	228.98	206.12	11	935.28	804.33	16
PBT	159.41	128.87	24	655.78	488.87	34
NP	281.61	93.84	200	619.52	351.84	76

Powered by Capital Market - Live News